Special Notice NAICS 541714

Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)

🏢 HEALTH AND HUMAN SERVICES, DEPARTMENT OF 📅 Posted 2025-10-01 ⏳ Due 2025-10-02T12:59:00+00:00
The purpose of this amendment is to: 1. Extend the registration deadline for lightning talks and sidebars to October 2, 2025 at 08:59AM ET. 2. Extend the available days/hours for lightning talks and sidebars. Lightning talks and sidebars slots will now be available on October 3. 2025. Slots for the October 3rd lightning talks and sidebars will be available between 11:00AM ET to 2:00PM ET. In addition, slots for the October 2nd sidebars will now be available between 11:00AM ET and 7:00PM ET. Please see the revised Special Notice document for additional details. ------------------------------------------------------------------------------------------------------------ This Special Notice (SN) is intended to alert the scientific community to a newly approved ARPA-H Program and notify potential proposers of an associated Proposers’ Day (PD). Under the cognizance of HSF, ARPA-H is publishing an Innovative Solutions Opening (ISO) for the Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program no later than September 25, 2025, please monitor SAM.gov for updates (ARPA-H-SOL-25-122). For additional PD details and registration information see the attached...

Notice ID: 6b7827d3aa4a4a998fe255808dbb8b86 · View on SAM.gov ↗

Explore more federal-contracting data

Browse opportunities by NAICS code · set-aside category · state & jurisdiction · buying agency

Win more federal contracts

BidChamp gives small businesses AI-powered bid writing, document analysis, and recompete forecasting - for free during your trial.

Sign up free - 14-day trial, no card required